by Clinical Neuropsychologist Online | Tuesday, July 30, 2024 | Dementia
Abstract The COVID pandemic has shown that when the research community comes together, we can conquer the most complex biomedical challenges. Collaboration and teamwork among federal agencies, private organizations, and researchers have been crucial in the development...
by Clinical Neuropsychologist Online | Tuesday, July 30, 2024 | Dementia
Abstract INTRODUCTION The degeneration of cortical layers is associated with cognitive decline in Alzheimer’s disease (AD). Current therapies for AD are not disease-modifying, and, despite substantial efforts, research and development for AD has faced formidable...
by Clinical Neuropsychologist Online | Tuesday, July 30, 2024 | Dementia
Abstract INTRODUCTION Plasma has been proposed as an alternative to cerebrospinal fluid (CSF) for measuring Alzheimer’s disease (AD) biomarkers, but no studies have analyzed in detail which biofluid is more informative for genetics studies of AD. METHOD Eleven...
by Clinical Neuropsychologist Online | Tuesday, July 30, 2024 | Neurorehabilitation
Neurorehabilitation and Neural Repair, Volume 38, Issue 8, Page 616-632, August 2024. BackgroundA growing number of studies has combined transcranial direct current stimulation (tDCS) with other non-invasive non-pharmacological therapies (NINPT) to enhance effects in...
by Clinical Neuropsychologist Online | Tuesday, July 30, 2024 | Neurorehabilitation
Neurorehabilitation and Neural Repair, Volume 38, Issue 9, Page 635-645, September 2024. BackgroundWalking abnormalities in people with Parkinson’s disease (PD) are characterized by a shift in locomotor control from healthy automaticity to compensatory, executive...
